Medfield, MA, United States of America

David P Hill


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of David P. Hill in Ocular Therapeutics

Introduction: David P. Hill, an accomplished inventor based in Medfield, MA, has made significant strides in the field of ocular therapeutics. With a groundbreaking patent to his name, Hill is recognized for his innovative approach to delivering therapeutic agents into ocular tissue, showcasing his commitment to advancing medical technology and patient care.

Latest Patents: David P. Hill holds a patent for an "Electrode Assembly for Delivering a Therapeutic Agent into Ocular Tissue." This patent describes a contact electrode assembly designed to administer therapeutic agents effectively. The innovative assembly includes a flexible dielectric layer, a first electrode portion, and a second electrode portion, offering a sophisticated solution for ocular treatments. The interdigitated electrode design, featuring comb-shaped portions that enhance the delivery process, illustrates Hill's expertise in marrying technology with healthcare.

Career Highlights: Hill's career is marked by his role at The Cleveland Clinic Foundation, a prestigious institution known for its cutting-edge research and patient care initiatives. His work at the clinic has allowed him to collaborate with leading professionals in the medical and engineering fields, amplifying the impact of his innovations.

Collaborations: Throughout his career, David P. Hill has worked alongside notable colleagues such as Rishi P. Singh and William G. Lionetta. Their collaboration has fostered an environment of innovation, driving advancements in ocular treatments and expanding the potential applications of Hill's patented technologies.

Conclusion: David P. Hill's contributions to ocular therapeutics highlight his role as a visionary inventor. With his patented electrode assembly, he has opened new avenues for the delivery of therapeutic agents, enhancing the landscape of ocular treatment. His collaboration with esteemed colleagues at The Cleveland Clinic Foundation further amplifies his impact, solidifying his legacy in the medical innovation sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…